Treatment of depression and anxiety in Parkinson’s Disease

QR Code

Treatment of depression and anxiety in Parkinson’s Disease

This thesis examined the treatment of depression and anxiety in Parkinson’s disease (PD) and comprised four studies. Study 1 was a meta-analysis of treatments for depression and anxiety in PD. Study 2 examined the validity of the DASS-21 as an assessment tool in PD. Study 3 was a randomised controll...

Full description

Bibliographic Details
Main Author:	Troeung, Lakkhina
Format:	Thesis
Language:	English
Published:	Curtin University 2013
Online Access:	http://hdl.handle.net/20.500.11937/1044

Similar Items

A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease
by: Troeung, Lakkhina, et al.
Published: (2014)

A meta-analysis of randomized placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease
by: Troeung, L., et al.
Published: (2013)

Patterns and Predictors of Mental Health Service Utilization in People With Parkinson's Disease
by: Troeung, Lakkhina, et al.
Published: (2014)

Clinical issues in the treatment of anxiety and depression in older adults with Parkinson’s disease
by: Pachana, N., et al.
Published: (2013)

Suitability of the depression, anxiety, and stress scale in Parkinson's disease
by: Johnson, A., et al.
Published: (2016)

Cognitive behaviour therapy for depression and anxiety in Parkinson's disease
by: Egan, Sarah, et al.
Published: (2015)

Treatment of depression and anxiety iin Parkinson's Disease: a pilot study using group cogntive behavioural therapy
by: Feeney, Farah, et al.
Published: (2005)

Activities of Daily Living, Depression, and Quality of Life in Parkinson’s Disease
by: Lawrence, B., et al.
Published: (2014)

Literature Review on Acupuncture Treatment for Parkinson’s Disease
by: Teng, Le-xus, et al.
Published: (2024)

Cognitive Training and Noninvasive Brain Stimulation for Cognition in Parkinson's Disease: A Meta-analysis.
by: Lawrence, B., et al.
Published: (2017)

Parkinson’s Disease - A review on treatment strategies and its advances
by: Subashini, Raman, et al.
Published: (2020)

Modified Mindfulness-Based Cognitive Therapy for Depressive Symptoms in Parkinson's Disease: A Pilot Trial
by: Rodgers, S., et al.
Published: (2019)

Measuring General Expectations of Advanced Stage Treatment Outcomes in Parkinson's Disease
by: Loftus, Andrea, et al.
Published: (2021)

The unified parkinson's disease rating scale score in parkinson's disease patients with and without cognitive impairment
by: Hilmi, Abdullah
Published: (2007)

The Measurement and Nature of Impulsivity in Parkinson’s disease
by: Booth, Leon David
Published: (2020)

Beneficial role of vitexin in Parkinsons disease
by: Mustapha, Musa, et al.
Published: (2023)

An open trial of brief transdiagnostic internet treatment for anxiety and depression
by: Dear, B., et al.
Published: (2011)

The involvement of people with Parkinson’s in designing a study of the lived experience of anxiety
by: Lovegrove, C., et al.
Published: (2017)

Transgenic nematodes as a model for Parkinson’s disease
by: Bodhicharla, Rakesh Kumar
Published: (2012)

Analysis of mitochondrial haemoglobin in Parkinson's disease brain
by: Shephard, Freya, et al.
Published: (2016)

Assessment of depression, anxiety and stress symptoms among patients with periodontal disease
by: Al-Ani, Ali Sabri Radeef, et al.
Published: (2017)

Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease
by: Doering, L., et al.
Published: (2010)

Transdiagnostic internet treatment for anxiety and depression: A randomised controlled trial
by: Titov, N., et al.
Published: (2011)

Intelligent glove for suppression of resting tremor in parkinson’s disease
by: M. Zulkefli, Adibah, et al.
Published: (2019)

Cognitive reserve, executive function, and memory in parkinson’s disease
by: Loftus, Andrea, et al.
Published: (2021)

Predicting Parkinson’s Disease Using Machine Learning Model
by: Sanjay Aswath, K.S.M, et al.
Published: (2024)

Limbic grey matter changes in early Parkinson's disease
by: Li, Xingfeng, et al.
Published: (2017)

Nonpharmacological Interventions for Mild Cognitive Impairment in Parkinson’s Disease
by: Lawrence, Blake Justin
Published: (2016)

A Bayesian Evaluation of Subtyping Methods in Parkinson’s Disease
by: Johnson, Andrew Robert
Published: (2019)

Factor Structure of the Ways of Coping Questionnaire in Parkinson's Disease
by: Corti, E., et al.
Published: (2018)

Motor Heterogeneity in Parkinson's Disease: A Bayesian Perspective
by: Johnson, A., et al.
Published: (2017)

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
by: Lawrence, B., et al.
Published: (2016)

Validity of driving simulator in assessing drivers with Parkinson's Disease
by: Lee, Hoe, et al.
Published: (2008)

Concurrent validity of the depression and anxiety components in the Bahasa Malaysia version of the depression anxiety and stress scales (DASS)
by: Musa, Ramli, et al.
Published: (2011)

Concurrent validity of the depression and anxiety components in the Bahasa Malaysia version of the Depression Anxiety and Stress Scale (DASS)
by: Musa, Ramli, et al.
Published: (2011)

Anxiety and depression in end-stage COPD
by: Hill, Kylie, et al.
Published: (2008)

Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease
by: Reyes, S., et al.
Published: (2013)

Application of neural networks in early detection and diagnosis of parkinson's disease
by: Olanrewaju, Rashidah Funke, et al.
Published: (2014)

Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
by: Salama, Mohamed, et al.
Published: (2018)

Insights into Parkinson’s disease from computational models of the basal ganglia
by: Humphries, Mark D., et al.
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mu7sjjql6c0r6np0jcrarbguul